𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Tumor necrosis factor: An update on basic research and clinical applications

✍ Scribed by Schleuning, M. ;Munker, R.

Publisher
Springer-Verlag
Year
1990
Tongue
English
Weight
697 KB
Volume
68
Category
Article
ISSN
1432-1440

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Update on basic research and clinical ex
Update on basic research and clinical experience with metaiodobenzylguanidine
✍ Beierwaltes, William H. πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 669 KB

I 131-metaiodobenzylguanidine (MIBG) is an aralkylguanidine with certain structural similarities to norepinephrine (NE). It is concentrated, stored, and released from chromaffin granules in a manner almost identical with that of NE. It will image the enlarged adrenal medullae of adrenal medullary hy

Injection of recombinant tumor necrosis
Injection of recombinant tumor necrosis factor directly into liver metastases: an experimental and clinical approach
✍ Jan N. M. IJzermans; Marcel Scheringa; George P. Schelling; Rob A. Geerling; Ric πŸ“‚ Article πŸ“… 1992 πŸ› Springer 🌐 English βš– 597 KB

Systemic treatment with tumor necrosis factor (TNF) is associated with side-effects, limiting its clinical use in the treatment of malignancies. To investigate the feasibility of other routes of administration experimental and clinical studies were started to establish the toxicity and antitumor act

UICC study group on basic and clinical c
UICC study group on basic and clinical cancer research: Genotypes and phenotypes of tumor suppressors
✍ Arnold J. Levine; Max M. Burger πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 French βš– 301 KB πŸ‘ 1 views

It is the purpose of these Study Group Meetings, which are organized by the UICC Tumor Biology Program, to establish a basis for possible clinical applications founded on molecular concepts. For this purpose a few clinicians, pathologists and epidemiologists are regularly invited to the meetings, wh